DK260588A - Heterocykliske ketoner - Google Patents

Heterocykliske ketoner

Info

Publication number
DK260588A
DK260588A DK260588A DK260588A DK260588A DK 260588 A DK260588 A DK 260588A DK 260588 A DK260588 A DK 260588A DK 260588 A DK260588 A DK 260588A DK 260588 A DK260588 A DK 260588A
Authority
DK
Denmark
Prior art keywords
formula
compounds
pharmaceutically acceptable
ketons
heterocyclic
Prior art date
Application number
DK260588A
Other languages
English (en)
Other versions
DK260588D0 (da
Inventor
Philip Duke Edwards
Joseph James Lewis
Charles William Perkins
Diane Amy Trainor
Richard Alan Wildonger
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878711050A external-priority patent/GB8711050D0/en
Priority claimed from GB888803206A external-priority patent/GB8803206D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of DK260588D0 publication Critical patent/DK260588D0/da
Publication of DK260588A publication Critical patent/DK260588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK260588A 1987-05-11 1988-05-11 Heterocykliske ketoner DK260588A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878711050A GB8711050D0 (en) 1987-05-11 1987-05-11 Selected heterocyclic ketones
GB888803206A GB8803206D0 (en) 1988-02-11 1988-02-11 Selected heterocyclic ketones

Publications (2)

Publication Number Publication Date
DK260588D0 DK260588D0 (da) 1988-05-11
DK260588A true DK260588A (da) 1988-11-12

Family

ID=26292230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260588A DK260588A (da) 1987-05-11 1988-05-11 Heterocykliske ketoner

Country Status (22)

Country Link
US (1) US5164371A (da)
EP (1) EP0291234B1 (da)
JP (1) JPS6445395A (da)
KR (1) KR880013926A (da)
CN (1) CN1037519A (da)
AT (1) ATE103293T1 (da)
AU (1) AU605284B2 (da)
CA (1) CA1326107C (da)
DE (1) DE3888568T2 (da)
DK (1) DK260588A (da)
ES (1) ES2063034T3 (da)
FI (1) FI91072C (da)
GB (1) GB8809316D0 (da)
HU (1) HU201963B (da)
IE (1) IE62524B1 (da)
IL (1) IL86236A (da)
NO (1) NO176519C (da)
NZ (1) NZ224452A (da)
PT (1) PT87454B (da)
SU (1) SU1678207A3 (da)
ZA (1) ZA883006B (da)
ZW (1) ZW4988A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
GB8910550D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted amides
ES2129401T3 (es) * 1990-05-24 1999-06-16 Zeneca Ltd Uso de un compuesto terapeutico para el tratamiento de bronquitis.
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
IE911697A1 (en) * 1990-05-24 1991-12-04 Zeneca Ltd Therapeutic agent
EP0475531B1 (en) * 1990-09-10 1995-01-18 Asahi Kasei Kogyo Kabushiki Kaisha Benzoic acid phenylester compounds and elastase inhibiting compositions containing the same
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US20020119985A1 (en) * 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US5556990A (en) * 1994-12-16 1996-09-17 Rhone-Poulenc Rorer Pharmaceuticals Inc. Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
EP0977772A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6274602B1 (en) * 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US6255453B1 (en) 1998-06-03 2001-07-03 Cortech, Inc. Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
WO2000056724A1 (en) * 1999-03-22 2000-09-28 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Oxazole and thiazole combinatorial libraries
CA2375229A1 (en) * 1999-06-17 2000-12-28 Source Precision Medicine, Inc. Method and compounds for inhibiting activity of serine elastases
WO2002051983A2 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
MXPA04002282A (es) 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Nuevos compuestos y preparaciones como inhibidores de la catepsina.
EP1446392A1 (en) 2001-11-14 2004-08-18 Aventis Pharmaceuticals, Inc. Oligopeptides and compositions containing them as cathepsin s inhibitors
PL371539A1 (en) * 2002-02-05 2005-06-27 Dainippon Pharmaceutical Co, Ltd. Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
CA2482207A1 (en) * 2002-04-16 2003-10-23 Axys Pharmaceuticals, Inc. Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
JP3744890B2 (ja) 2002-11-01 2006-02-15 ハッピー工業株式会社 ミシン
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP2019837B1 (en) * 2006-05-23 2011-03-23 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2027143A2 (en) 2006-05-23 2009-02-25 Irm Llc Compounds and compositions as channel activating protease inhibitors
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
CA2677487A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
FR2914920B1 (fr) 2007-04-11 2011-09-09 Clariant Specialty Fine Chem F Procede de deacetalisation d'alpha-aminoacetals.
FR2916441B1 (fr) 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.
WO2009007415A2 (en) * 2007-07-10 2009-01-15 Probiodrug Ag Novel compounds
US20090156509A1 (en) * 2007-12-12 2009-06-18 Accuthera, Inc. Tri-peptide Inhibitors of Serine Elastases
FR2927900B1 (fr) 2008-02-27 2010-09-17 Clariant Specialty Fine Chem Procede de preparation d'alpha-aminoacetals optiquement actifs.
HRP20251570T1 (hr) * 2019-12-20 2026-01-30 Pfizer Ireland Pharmaceuticals Unlimited Company Djelotvoran postupak dobivanja derivata 6-karboksibenzoksazola

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124317B1 (en) * 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
JPH03505210A (ja) * 1988-09-09 1991-11-14 ユニバーシティー オブ ケンタッキー リサーチ ファウンデーション エラスターゼ阻害ポリマーおよび方法
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones

Also Published As

Publication number Publication date
IL86236A (en) 1994-12-29
ES2063034T3 (es) 1995-01-01
FI91072B (fi) 1994-01-31
DE3888568T2 (de) 1994-07-21
IE62524B1 (en) 1995-02-08
NO176519B (no) 1995-01-09
ATE103293T1 (de) 1994-04-15
NO882036D0 (no) 1988-05-10
IE881416L (en) 1988-11-11
AU1539088A (en) 1988-11-17
FI882176A0 (fi) 1988-05-10
EP0291234A3 (en) 1990-08-22
CN1037519A (zh) 1989-11-29
JPS6445395A (en) 1989-02-17
FI882176A7 (fi) 1988-11-12
AU605284B2 (en) 1991-01-10
EP0291234A2 (en) 1988-11-17
FI91072C (fi) 1994-05-10
NO882036L (no) 1988-11-14
US5164371A (en) 1992-11-17
SU1678207A3 (ru) 1991-09-15
DE3888568D1 (de) 1994-04-28
ZW4988A1 (en) 1989-12-06
NO176519C (no) 1995-04-19
HU201963B (en) 1991-01-28
CA1326107C (en) 1994-01-11
IL86236A0 (en) 1988-11-15
PT87454B (pt) 1992-08-31
EP0291234B1 (en) 1994-03-23
GB8809316D0 (en) 1988-05-25
PT87454A (pt) 1989-05-31
KR880013926A (ko) 1988-12-22
HUT46708A (en) 1988-11-28
DK260588D0 (da) 1988-05-11
NZ224452A (en) 1991-06-25
ZA883006B (da) 1988-11-11

Similar Documents

Publication Publication Date Title
DK260588D0 (da) Heterocykliske ketoner
ATE204873T1 (de) Naphthyridinderivate als angiotensin-ii- antagonist-inhibitoren
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ES2065182T3 (es) Derivados de fenilamidinas utiles como inhibidores de la agregacion de plaquetas.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
DE69200160D1 (de) Angiotensin-II-Antagonisten.
EP0276101A3 (en) Substituted peptide derivatives
DE69332366D1 (de) Arylsubstituierte heterocyclische Verbindungen
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
DK23089A (da) Thioformamidderivater og deres anvendelse
JPS5716841A (en) Novel compound,manufacture,bactericidal composition and use
DE69208384D1 (de) Fungizide Furanonderivate

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment